Hook and thesis
TTM Technologies (TTMI) just delivered a beat-and-raise quarter yet the stock has been punished on execution worries and rising interest costs. Management reported Q3 non-GAAP EPS of $1.46 (up 118% year-over-year) on revenue of $1.2 billion (up 60% year-over-year) and then guided to $6.5B-$6.75B of revenue for 2027 with EPS guidance of $8.10-$8.90. Despite that, the market is acting like TTMI has already hit its peak. We think that is premature. The company's AI-driven data center exposure, a $1.7 billion defense backlog, and a planned $400 million capacity expansion for 2028 suggest the demand curve is still rising for at least the next 24 months.
Put simply: Wall Street is selling a peak that is at least two years away. That creates a tactical, actionable long trade with asymmetric upside versus downside if management executes on capacity and supply-chain fixes.
What TTM does and why the market should care
TTM manufactures printed circuit boards, backplane assemblies and RF/specialty components across three segments: Aerospace & Defense (A&D), Commercial, and RF & Specialty. Customers include data center and networking firms (where AI demand is concentrated), medical, automotive and defense contractors. The revenue mix matters because the AI cycle is skewing demand toward high-layer-count PCBs and backplane assemblies that command higher margins.
Why investors should care: TTMI is at the intersection of two durable secular tailwinds. First, AI and hyperscale data center buildouts are driving a step-up in demand for advanced PCB assemblies - management said Data Center/Networking sales were up 115% in the quarter. Second, rising defense budgets are supporting a solid A&D backlog (management cites roughly $1.7 billion). That combo supports multi-year top-line growth rather than a short, one-year spike.
Recent performance - the numbers that matter
- Q3 2026 revenue: $1.20 billion, +59.9% year-over-year, beat estimates.
- Q3 2026 non-GAAP EPS: $1.46, +117.9% year-over-year, also a beat.
- 2027 guidance: Revenues $6.50B - $6.75B; EPS $8.10 - $8.90. Management also announced a $400M capacity expansion planned for 2028.
- Margins and cash flow: adjusted EBITDA margin reported near 20.1% in commentary; free cash flow was negative at -$15.14M on the snapshot trailing numbers, signaling near-term working capital and capex pressure.
- Market snapshot: Market cap approximately $9.0 billion, enterprise value roughly $8.905 billion, EV/EBITDA ~18.2 and trailing P/E in the low-30s by reported figures.
Valuation framing
At about a $9.0 billion market cap and an EV around $8.9 billion, the stock trades at EV/EBITDA ~18x and a trailing P/E in the low-30s. Those multiples look rich on trailing numbers, but the company has provided guidance implying an EPS run-rate in the mid-to-high single digits for FY2027. Using a simple sanity check: if TTMI earns $8.50 in 2027 (midpoint of guidance) and the market awards it a more normalized manufacturing multiple of 18x forward EPS, fair value would be roughly $153. That is consistent with the company's own growth signaling via capacity expansion and defense backlog.
Put another way, the stock’s 52-week high of $223 in June reflected an elevated multiple during peak sentiment. The current price near $87 is pricing in either a permanent collapse in demand or severe execution failure. We view both scenarios as unlikely. Debt is manageable - debt-to-equity ~0.5 - but interest expense is rising due to recent acquisitions and leverage; that is real and explains some of the de-rating. Still, the forward earnings power is the bigger driver and is likely to re-rate as revenue and margin visibility improves.
Technical and sentiment snapshot
Technical indicators show that momentum has cooled - RSI around 37 and MACD in bearish momentum - but short interest increased recently to nearly 5.0 million shares settled on 10/15, with days-to-cover under two. That combination can exaggerate downside in the short term but also sets the stage for a quick rebound once execution concerns ease and lead times normalize. Volume has been elevated: the stock traded over 8 million shares on the latest session that pushed the price back up towards $87.
Trade plan - actionable, with horizon, entry, stop and target
Trade Direction: Long
Entry price (exact): $87.02
Stop loss (exact): $65.00
Target price (exact): $150.00
Time horizon: long term (180 trading days). Rationale: The path to $150 is unlikely to be linear. The thesis depends on execution of the 2028 capacity expansion, stabilization of supply-chain lead times, and realization of 2027 revenue/EPS guidance. Those are multi-quarter developments; give the trade at least 180 trading days to play out so new capacity comes into view and backlog converts to revenue.
Position sizing guidance: treat this as a medium-risk trade. Use a position size that limits portfolio-level drawdown to a comfortable percentage if the stop is hit, because supply-chain or macro-driven downside could be sharp.
Catalysts that could drive the trade higher
- Evidence of lead-time normalization - reduction from current extended 24-week component lead times to industry norms would directly improve on-time delivery and revenue conversion.
- Quarterly beats with margin expansion - consecutive quarters of revenue beats and improving adjusted EBITDA margin toward management commentary (around 20% level) would force a re-rate.
- Successful ramp of the Syracuse Ultra-HDI facility and other capacity additions ahead of the 2028 expansion timeline, which would give investors confidence in the company’s ability to scale for AI demand.
- Defense contract wins or backlog conversion - meaningful A&D revenue growth from the $1.7B backlog showing up in bookings and revenue recognition.
Risks and counterarguments
At least four risks to consider:
- Supply-chain and execution risk - management disclosed component lead times stretched to 24 weeks, and that caused a 10% miss in the data center division in the most recent quarter. Continued bottlenecks could delay revenue realization and compress margins.
- Rising interest expense and leverage - recent acquisitions have increased interest costs by roughly $20M per quarter. If rates remain elevated or acquisitions fail to accrete quickly, free cash flow could stay negative and capex plans could be delayed.
- Execution on capacity expansion - the $400M expansion for 2028 is necessary to capture the AI opportunity. Delays, cost overruns or lower-than-expected utilization would undermine the growth case.
- Competitive pressure - established defense and PCB competitors such as Curtiss-Wright and Mercury Systems could win share in aerospace and defense, pressuring margins and backlog conversion.
- Valuation re-rating risk - if investors decide the AI data center cycle is shorter-lived than expected, multiples could compress further from already-depressed levels.
Counterargument: The sell-off is not irrational. The company missed some data center targets due to lead times and faces increased interest burdens. Those are not trivial and could mean slower cash conversion and a higher cost of capital - both legitimate reasons for a derating. If supply chains remain stressed and interest expense rises further, the stock could easily trade below the $65 stop level.
What would change my mind
I would abandon this long trade if any of the following occur:
- Management materially reduces 2027 guidance or provides downgraded 2028 capacity plans, signaling demand is weakening rather than being supply-constrained.
- Free cash flow does not improve or turns significantly negative for multiple quarters, suggesting the company cannot fund capex without dilutive financing.
- Lead times extend further or the data center business shows consecutive revenue misses, indicating secular demand is softer than expected.
Conclusion and action steps
TTM Technologies is not a speculative story without backbone. It reported a strong quarter, provided multi-year guidance and is investing to capture structural AI and defense demand. The market’s reaction has created an asymmetric risk-reward: downside is limited to execution and supply-chain outcomes, while upside is substantial if management converts backlog and ramps capacity. For a long-term, event-driven trade, enter at $87.02, place a stop at $65.00 to limit downside on execution failure, and target $150.00 over the next 180 trading days.
This is a medium-risk, long-term trade that bets on supply-chain normalization and successful capacity execution. Monitor quarterly bookings, changes in lead times and reported interest expense closely; those data points will determine whether the rebound is sustainable.
Key data referenced in this note: Q3 revenue $1.20B, Q3 non-GAAP EPS $1.46, 2027 revenue guide $6.5B-$6.75B, 2027 EPS guide $8.10-$8.90, market cap approximately $9.0B, enterprise value ~$8.9B, EV/EBITDA ~18.2, free cash flow -$15.14M, debt-to-equity ~0.5.